Abstract
A recombinant DNA-modified strain of the filamentous fungus Cephalosporium acremonium, strain LU4-79-6, produced more of the antibiotic cephalosporin C than a non-recombinant strain, strain 394-4, from which it was derived by transformation. Strain 394-4, derived from C. acremonium ATCC 11550 by multiple rounds of mutagenesis and screening for improved antibiotic biosynthesis, has been useful for producing cephalosporin C at industrial scale. Strain LU4-79-6 has one insert of pPS56 DNA in its high molecular weight DNA. Plasmid pPS56 includes a dominant hygromycin B resistance marker and a 7 kb BamH1 C. acremonium DNA fragment containing the cefEF gene. The cefEF gene codes for a bifunctional protein that exhibits two sequentially-acting cephalosporin biosynthetic enzyme activities: deacetoxycephalosporin C synthetase (DAOCS) and deacetylcephalosporin C synthetase (DACS). Extracts of strain LU4-79-6 contained ∼2-fold more DAOCS activity than corresponding extracts of its non-recombinant parent. Strain LU4-79-6 excretes less penicillin N, the substrate of DAOCS, than strain 394-4. Resistance to hygromycin B, presence of pPS56 DNA, elevated intracellular DAOCS, decreased penicillin N production, and increased cephalosporin C production are retained after growth in a medium free of hygromycin B. The superiority of the recombinant strain has been confirmed at pilot scale.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bunnell, C.A., Luke, W.D., and Perry, R.M. Jr. 1986. Industrial manufacture of cephalosporins, p. 255–284. In Beta-lactam Antibiotics for Clinical Use S.F. Queener, J A. Weber, and S.W Queener (Eds.) Marcel Dekker, Inc, New York, New York.
Queener, S.F. 1986. History and origin of the beta-lactam antibiotics, p. 3–13. In: Beta-lactam Antibiotics for Clinical Use. S. F. Queener, J.A. Weber, and S.W. Queener (Eds.). Marcel Dekker, Inc, New York, New York.
Queener, S.W. and Lively, D.H. 1986. Screening and selection for strain improvement, p. 155–169. In: Manual of Industrial Microbiology and Biotechnology. A. L. Demam and N. A. Solomon (Eds.) American Society for Microbiology, Washington, D.C.
Queener, S.W. and Neuss, N. 1982. The biosynthesis of the betalactam antibiotics, p. 1–100. In: Chemistry and Biology of Beta-Lactam Antibiotics, Vol. 3. R.B. Morin and M. Gorman (Eds). Academic Press, New York.
Abraham, E.P. 1986. Biosynthesis of penicillins and cephalosporins, p.103–116. In Beta-lactam Antibiotics for Clinical Use. S.F. Queener, J A. Weber, and S.W Queener (Eds.). Marcel Dekker, Inc, New York, New York.
Dotzlaf, J.E. and Yeh, W.-K. 1987. Copurification and characterization of deacetyoxycephalosporin C synthetase/hydroxylase from Cephalosporium acremonium . J. Bacteriology. 169:1611–1618.
Scheidigger, A., Kuenzi, M.T. and Nuesch, J. 1984. Partial purification and catalytic properties of a bifunctional enzyme in the biosynthetic pathway of beta-lactams in Cephalosporium acremonium . J. Antibiot. 37:522.
Samson, S.M., Belagaje, R., Blankenship, D.T., Chapman, J.L., Perry, D., Skatrud, P.L., VanFrank, R.M., Abraham, E.P., Baldwin, J.E., Queener, S.W. and Ingolia, T.D. 1985. Isolation, sequence determination and expression in Eschenchia coli of the isopenicillin N synthetase gene from Cephalosporium acremonium . Nature 311:191–194
Samson, S.E., Dotzlaf, J.E., Slisz, M.L., Becker, G.W., Van Frank, R.M., Veal, L.E. Yeh, W.-K. Miller, J.R. Queener, S.W. and Ingolia, T.D. 1987. Cloning and expression of the fungal expandase/ hydroxylase gene involved in cephalosporin C biosynthesis. Bio/Technology 5:1207–1214.
Samson, S.M., Chapman, J.L., Belagaje, R., Queener, S.W. and Ingolia, T.D. 1987. Analysis of the role of cysteine residues in isopenicillin N synthetase activity by site-directed mutagenesis. Proc. Natl. Acad. Sci. USA. 84:5705–5709.
Kaster, K.R., Burgett, S.G. and Ingolia, T.D. 1984. Hygromycin B resistance as a dominant marker in yeast. Curr. Genet. 8:353–358.
Queener, S.W., Ingolia, T.D., Skatrud, P.L., Chapman, J.L. and Kaster, K.R. 1985. A system for genetic transformation of Cephalosporium acremonium, p. 468–472. In Microbiology 1985. L. Leive (Ed.). American Society for Microbiology, Washington, D.C.
Skatrud, P.L. and Queener, S.W. 1984. Cloning of a DNA fragment from Cephalosporium acremonium, which functions as an autonomous replication sequence in yeast. Curr. Genet. 8:155–163.
Carr, L.G., Skatrud, P.L., Ingolia, T.D. and Queener, S.W. 1987. Organization of the 5.8S, 16–18S, and 23–28S ribosomal RNA genes of Cephalosporium acremonium . Curr. Genet. 12:209–214
Skatrud, P.L., Queener, S.W., Carr, L.G. and Fisher, D.L. 1987. Efficient integrative transformation of Cephalosporium acremonium . Curr. Genetics. 12:337–348.
Chapman, J.L., Skatrud, P.L., Ingolia, T.D., Samson, S.M., Kaster, K.R. and Queener, S.W., 1987. Recombinant DNA studies Cephalosporium acremonium, p. 165–174. In: Developments in Industrial Microbiology, Vol. 27. G. Pierce, (Ed.). Society for Industrial Microbiology.
Skatrud, P.L., Fisher, D.L., Ingolia, T.D. and Queener, S.W. 1986. Improved transformation of Cephalosporium acremonium, p. 111–119. In: The Proceedings of the Fifth International Symposium on the Genetics of Industrial Microorganisms. M. Alacevic, D Hranueli, and Z. Toman, (Eds.). Pliva, Zagreb, Yugoslavia.
Newton, G.G.F. and Abraham, E.P. 1955. Cephalosporin N: A new type of penicillin. Nature. 175:548.
Neuss, N, Berry, D.M., Kupka, J., Demian, A.L., Queener, S.W., Duckworth, D.C. and Huckstep, L.L. 1982. High performance liquid chromatography of natural products. V. The use of HPLC in the cell-free biosynthetic conversion of alpha-aminoadipyl-cysteinyl-valine (LLD) into isopenicillin N. J. Antibiotics. 35:580–584
Usher, J.J., Lewis, M. and Hughes, D.W. 1985. Determination by HPLC of some compounds involved in the biosynthesis of penicillin and cephalosporin. Anal. Chem. 149:105–110.
Roggenkamp, R., Kustermann-Kuhn, B. and Hollenberg, C.P. 1981. Expression and processing of bacterial β-lactamase in the yeast Saccharomyces cerevisiae . Proc. Natl. Acad. Sci. USA. 78:4466–4470
Skatrud, P.L. and Queener, S.W. 1989. An electrophoretic molecular karyotype for Cephalosporium acremonium . Gene. In press.
Hilgendorf, P., Heiser, V., Diekmann, H. and Thoma, M. 1987. Constant dissolved oxygen concentrations in cephalosporin C fermentation: Applicability of different controllers and effect on fermentation parameters. Appl. Microbiol. Biotechnol. 27:247–251.
Huber, F.M., Baltz, R.H. and Caltrider, P.G., 1968. Formation of desacetylcephalosporin C in cephalosporin C fermentations. Applied Micro. 16:1011–1014.
Hinnen, A. and Nuesch, J. 1976. Enzymatic hydrolysis of cephalosporin C by an extracellular acetylhydrolase of Cephalosporium acremonium . Antimicrobial Agents and Chemotherapy. 9:824–830.
Meselson, M. and Yuan, R. 1968. DNA restriction enzyme from E. coli Nature. 217:1110–1114
Levinson, A., Silver, D. and Seed, B. 1984. Minimal size plasmids containing an M13 origin for production of single-strand transducing particles. J. Mol. Appl. Genet. 2:507–517.
Skatrud, P.L. 1986. Recombinant DNA Studies in Cephalosporium acremonium . Ph.D. Thesis. Indiana University, Bloomington, IN.
Queener, S.W., Wilkerson, S., Tunin, D.R., McDermott, J.P., Chapman, J.L., Nash, C., Platt, C. and Westpheling, J. 1984. Cephalosporin C fermentation: Biochemical and regulatory aspects of sulfur metabolism, p. 141–170. In: Biotechnology of Industrial Antibiotics. E.J. Vandamme, Marcel Dekker Inc. New York, Basel.
Redstone, M.O. 1971. A specific chemical assay for the acetyl moiety of cephalosponns. Prog. Abstr. Intersci., Conf. Antimicrob. Ag. Chemother., 11th, Atlantic City, N J., Abstr. 73, p. 37.
Niedermayer, A.O., Russo-Alesi, S.M., Lendzain, C.A. and Kelly, J.M. 1960. Automated system for continuous determination of penicillin in fermentation medium using hydroxylamine reagent. Anal. Chem. 32:664–666.
Huber, F.M. and Tietz, A.J. 1983. Defined media strategies for the biosynthesis of Cephalosporin C. Biotech. Letters. 5:385–390.
Ingolia, T.D. and Queener, S.W. 1989. Beta-lactam Biosynthetic Genes. Medicinal Chemistry Reviews. In Press.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Skatrud, P., Tietz, A., Ingolia, T. et al. Use of Recombinant DNA to Improve Production of Cephalosporin C By Cephalosporium acremonium. Nat Biotechnol 7, 477–485 (1989). https://doi.org/10.1038/nbt0589-477
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nbt0589-477
This article is cited by
-
Advancement in bioprocess technology: parallels between microbial natural products and cell culture biologics
Journal of Industrial Microbiology and Biotechnology (2017)
-
Comparison of the secondary metabolites in two scales of cephalosporin C (CPC) fermentation and two different post-treatment processes
Journal of Industrial Microbiology and Biotechnology (2013)
-
Expression of cefF significantly decreased deacetoxycephalosporin C formation during cephalosporin C production in Acremonium chrysogenum
Journal of Industrial Microbiology and Biotechnology (2012)
-
Industrial production of β-lactam antibiotics
Applied Microbiology and Biotechnology (2003)